酵素免疫分析法市场按产品类型、技术、应用、检体类型、自动化程度、最终用户和地区划分

预计到 2025 年，酵素免疫分析法市场规模将达到 191.4 亿美元，到 2032 年将达到 248.5 亿美元，2025 年至 2032 年的复合年增长率为 3.8%。

全球酵素免疫分析法市场是更广泛的诊断检测行业的重要组成部分，它结合了免疫反应的特异性和酶的催化特性，能够检测和定量多种生物物质。酵素免疫分析法酵素结合免疫吸附检测法（ELISA）将抗体-抗原交互作用与酵素反应相结合，产生可测量的讯号，从而能够精确检测临床检体中的蛋白质、荷尔蒙、病原体和其他生物标记。

这项技术已成为临床诊断、药物研发、食品安全检测和环境监测等多个领域不可或缺的一部分。市面上的产品种类繁多，旨在满足特定的分析需求，例如夹心ELISA、竞争性ELISA、间接ELISA和直接ELISA。随着人们越来越关注疾病早期检测、个人化医疗和就地检验，酵素免疫分析法也在不断发展，以提高灵敏度、特异性和快速出结果的能力。

市场动态

全球酵素免疫分析法市场的主要驱动力是糖尿病、心血管疾病、感染疾病和癌症等慢性疾病的日益流行，这些疾病使得全球医疗保健系统需要频繁的诊断监测和筛检计画。全球人口老化，加上人们健康意识的提高以及政府为促进预防性医疗保健所采取的倡议，都显着推动了对可靠诊断解决方案的需求。检测技术的发展，特别是多重检测平台、自动化系统和照护现场设备的引入，提高了检测效率并扩展了市场应用。然而，市场也存在诸多限制因素，例如诊断设备核准的严格监管要求。这些要求往往导致漫长而高成本的检验过程，从而延迟产品上市并增加研发成本。

先进酵素免疫分析法(EIA) 设备的高成本以及操作复杂系统需要熟练技术人员，构成了额外的障碍，尤其是在医疗预算有限的新兴市场。来自化学冷光免疫检测(CLIA)、分子诊断和快速抗原检测等替代诊断技术的竞争，带来了价格压力和市场份额挑战。然而，新兴市场也蕴藏着巨大的应用拓展机会，这些市场医疗基础设施的改善和可支配收入的成长正在推动对诊断服务的需求。人们对个人化医疗、伴随诊断和生物标记发现的日益关注，为市场成长开闢了新的途径，而人工智慧和数位健康平台的整合则有望提升检测效能和资料管理能力。

本次调查的主要特点

• 本报告对全球酵素免疫分析法市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和復合年增长率（%）。
• 它还重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
• 本报告根据以下参数介绍了全球酵素免疫分析法市场主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告的研究结果将有助于负责人和经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 这份全球酵素免疫分析法市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过全球酵素免疫分析法市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章 市场动态、监理及趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 重大进展
• 法规环境
• 产品上市及核准
• PEST分析
• 波特分析
• 併购趋势
• 产业趋势

4. 2020-2032年全球酵素免疫分析法市场（依产品类型划分）

• 试剂和试剂盒
• 分析仪/设备
• 软体和自动化系统
• 耗材和配件

5. 2020-2032年全球酵素免疫分析法市场（依技术划分）

• 酵素免疫分析法（ELISA）
• 酵素连结萤光测定法（ELFA）
• 化学冷光酵素免疫分析法（CL-EIA）
• 快速酵素免疫分析法
• 多重酵素免疫分析法

6. 2020-2032年全球酵素免疫分析法市场（依应用领域划分）

• 感染疾病诊断
• 肿瘤学
• 心臟病学
• 自体免疫疾病
• 内分泌学
• 药物监测与毒理学
• 过敏测试
• 其他的

7. 2020-2032年全球酵素免疫分析法市场（依检体类型划分）

• 血液/血清
• 尿
• 唾液
• 组织样本
• 其他（脑脊髓液、血浆）

8. 2020-2032年全球酵素免疫分析法市场（依自动化程度划分）

• 手动的
• 半自动
• 全自动

9. 2020-2032年全球酵素免疫分析法市场（依最终用户划分）

• 医院和诊所
• 诊断检查室
• 研究和学术机构
• 製药和生物技术公司
• 合约研究组织（CRO）

10. 2020-2032年全球酵素免疫分析法市场（按地区划分）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第十一章 竞争格局

• Abbott
• Roche Diagnostics
• Siemens Healthineers
• bioMerieux
• Beckman Coulter（Danaher）
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Revvity（PerkinElmer）
• DiaSorin
• QuidelOrtho
• EUROIMMUN（a Revvity company）
• Randox Laboratories
• Bio-Techne（R&D;Systems）
• Merck KGaA（MilliporeSigma）
• Tecan

第十二章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十三章 参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Enzyme Immunoassay Market is estimated to be valued at USD 19.14 Bn in 2025 and is expected to reach USD 24.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.8% from 2025 to 2032.

The global enzyme immunoassay market represents a critical segment within the broader diagnostic testing industry, leveraging the specificity of immunological reactions combined with the catalytic properties of enzymes to detect and quantify various biological substances. Enzyme immunoassays, also known as enzyme-linked immunosorbent assays (ELISA), utilize antibody-antigen interactions coupled with enzymatic reactions to produce measurable signals, enabling precise detection of proteins, hormones, pathogens, and other biomarkers in clinical samples.

This technology has become indispensable across multiple sectors including clinical diagnostics, pharmaceutical research, food safety testing, and environmental monitoring. The market encompasses various formats such as sandwich ELISA, competitive ELISA, indirect ELISA, and direct ELISA, each designed to address specific analytical requirements. With increasing emphasis on early disease detection, personalized medicine, and point-of-care testing, enzyme immunoassays have evolved to offer enhanced sensitivity, specificity, and rapid turnaround times.

Market Dynamics

The global enzyme immunoassay market is primarily driven by the escalating prevalence of chronic diseases including diabetes, cardiovascular disorders, infectious diseases, and cancer, which necessitate frequent diagnostic monitoring and screening programs across healthcare systems globally. The aging global population, coupled with increasing healthcare awareness and government initiatives promoting preventive healthcare, has significantly boosted demand for reliable diagnostic solutions. Technological advancements in assay development, including the introduction of multiplexed platforms, automated systems, and point-of-care devices, have enhanced testing efficiency and expanded market applications. However, the market faces substantial restraints including stringent regulatory requirements for diagnostic device approvals, which often result in lengthy and costly validation processes that can delay product launches and increase development expenses.

The high cost associated with advanced EIA instruments and the requirement for skilled technical personnel to operate sophisticated systems pose additional barriers, particularly in emerging markets with limited healthcare budgets. Competition from alternative diagnostic technologies such as chemiluminescent immunoassays (CLIA), molecular diagnostics, and rapid antigen tests creates pricing pressures and market share challenges. Nevertheless, significant opportunities exist in expanding applications within emerging markets, where improving healthcare infrastructure and increasing disposable incomes are driving demand for diagnostic services. The growing focus on personalized medicine, companion diagnostics, and biomarker discovery presents new avenues for market growth, while the integration of artificial intelligence and digital health platforms offers potential for enhanced assay performance and data management capabilities.

Key Features of the Study

• This report provides in-depth analysis of the global enzyme immunoassay market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global enzyme immunoassay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott, Roche Diagnostics, Siemens Healthineers, bioMerieux, Beckman Coulter (Danaher), Thermo Fisher Scientific, Bio-Rad Laboratories, Revvity (PerkinElmer), DiaSorin, QuidelOrtho, EUROIMMUN (a Revvity company), Randox Laboratories, Bio-Techne (R&D Systems), Merck KGaA (MilliporeSigma), and Tecan
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global enzyme immunoassay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enzyme immunoassay market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Reagents and Kits
  • Analyzers/Instruments
  • Software and Automation Systems
  • Consumables and Accessories
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Enzyme-Linked Fluorescent Assay (ELFA)
  • Chemiluminescent Enzyme Immunoassay (CL-EIA)
  • Rapid Test Enzyme Immunoassay
  • Multiplex Enzyme Immunoassay
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Infectious Disease Diagnostics
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Endocrinology
  • Drug Monitoring and Toxicology
  • Allergy Testing
  • Others
• Specimen Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Blood/Serum
  • Urine
  • Saliva
  • Tissue Samples
  • Others (CSF, Plasma)
• Automation Level Insights (Revenue, USD Bn, 2020 - 2032)
  • Manual
  • Semi-automated
  • Fully automated
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • Roche Diagnostics
  • Siemens Healthineers
  • bioMerieux
  • Beckman Coulter (Danaher)
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Revvity (PerkinElmer)
  • DiaSorin
  • QuidelOrtho
  • EUROIMMUN (a Revvity company)
  • Randox Laboratories
  • Bio-Techne (R&D Systems)
  • Merck KGaA (MilliporeSigma)
  • Tecan

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Enzyme Immunoassay Market, By Product Type
  • Global Enzyme Immunoassay Market, By Technology
  • Global Enzyme Immunoassay Market, By Application
  • Global Enzyme Immunoassay Market, By Specimen Type
  • Global Enzyme Immunoassay Market, By Automation Level
  • Global Enzyme Immunoassay Market, By End User
  • Global Enzyme Immunoassay Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Enzyme Immunoassay Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Reagents and Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Analyzers/Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Software and Automation Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Consumables and Accessories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Enzyme Immunoassay Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Enzyme-Linked Immunosorbent Assay (ELISA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Enzyme-Linked Fluorescent Assay (ELFA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chemiluminescent Enzyme Immunoassay (CL-EIA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rapid Test Enzyme Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multiplex Enzyme Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Enzyme Immunoassay Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Infectious Disease Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Autoimmune Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Drug Monitoring and Toxicology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Allergy Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Enzyme Immunoassay Market, By Specimen Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Blood/Serum
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Urine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Saliva
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tissue Samples
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (CSF, Plasma)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Enzyme Immunoassay Market, By Automation Level, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Manual
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Semi-automated
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fully automated
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Enzyme Immunoassay Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research and Academic Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Enzyme Immunoassay Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter (Danaher)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Revvity (PerkinElmer)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QuidelOrtho
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EUROIMMUN (a Revvity company)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Randox Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Techne (R&D Systems)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA (MilliporeSigma)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Tecan
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us